Melatonin protects aged oocytes from depalmitoylation-mediated quality reduction by promoting PPT1 degradation and antioxidation

Redox Biol. 2025 Mar:80:103510. doi: 10.1016/j.redox.2025.103510. Epub 2025 Jan 21.

Abstract

Oocyte aging is closely related to a decline in female fertility, accompanied by increased reactive oxygen species levels and changes in protein posttranslational modifications. However, the role of protein palmitoylation in oocyte aging has not been investigated. In the present study, a new association between redox and palmitoylation in aging oocytes was found. We found that the protein level of palmitoyl-protein thioesterase 1 (PPT1), a depalmitoylation enzyme, was increased in maternally aged mice oocytes and follicular fluid of aged (age >35 years) patients with decreased ovarian reserve (DOR). Elevated PPT1 led to decreased S-palmitoylation levels in oocytes, which impaired oocyte maturation and spindle formation. Tubulin was identified as a critical palmitoylated protein regulated by PPT1, whose palmitoylation was also decreased by advanced age, accompanied by abnormalities in membrane localization and microtubule polymerization. Melatonin was found to down-regulate excessive PPT1 and rescue PPT1-induced damage in mouse oocytes, not only by regulating oxidative stress, but also by binding with PPT1 to regulate its lysosomal degradation. In summary, our data demonstrate that PPT1 participates in oocyte aging by regulating tubulin palmitoylation, providing evidence that oxidative stress regulates protein palmitoylation and revealing a novel mechanism of oocyte aging.

Keywords: Antioxidation; Melatonin; Oocyte aging; Palmitoyl-protein thioesterase 1; Palmitoylation; Tubulin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Antioxidants* / pharmacology
  • Cellular Senescence* / drug effects
  • Female
  • Humans
  • Lipoylation / drug effects
  • Melatonin* / pharmacology
  • Mice
  • Oocytes* / cytology
  • Oocytes* / drug effects
  • Oocytes* / metabolism
  • Oxidation-Reduction
  • Oxidative Stress / drug effects
  • Proteolysis / drug effects
  • Reactive Oxygen Species / metabolism
  • Thiolester Hydrolases* / genetics
  • Thiolester Hydrolases* / metabolism
  • Tubulin / metabolism

Substances

  • Thiolester Hydrolases
  • palmitoyl-protein thioesterase
  • Melatonin
  • Tubulin
  • Antioxidants
  • Reactive Oxygen Species